National Right to Life supports Congressional Call for continued FDA restrictions on RU-486 abortion method
WASHINGTON–Congressman Jim Banks (R-IN) and Congressman Bob Latta (R-OH) along with many other pro-life members of Congress, submitted a letter to the acting commissioner of the Food and Drug Administration (FDA), Norman Sharpless, M.D., asking that the FDA retain the Risk Evaluation and Mitigation Strategy (REMS) that currently exists in relation to mifepristone (RU-486). RU-486 …
Continue reading "National Right to Life supports Congressional Call for continued FDA restrictions on RU-486 abortion method"